OrthoPediatrics Corp. Receives FDA approval for 3P™ Pediatric Plating Platform™ Small-Mini System, the second of several systems in the 3P family

Core Insights - OrthoPediatrics Corp. has received FDA approval for its 3P™ Pediatric Plating Platform™ Small-Mini System, marking the company's sixth FDA approval in 2025 [1][3]. Product Details - The 3P Small-Mini System is designed for pediatric orthopedic surgeons, featuring variable-angle locking implants and supporting a variety of trauma and deformity surgeries with plates in sizes 2.0mm, 2.4mm, 2.7mm, and 3.5mm [2]. - The system includes specialized instruments and color-coded trays to enhance surgical efficiency, following the successful launch of the 3P Hip System [2]. Company Strategy and Future Plans - The company aims to address unmet medical needs in pediatric orthopedics and plans a limited market release of the new system in early 2026 [3]. - OrthoPediatrics is committed to expanding its portfolio of innovative orthopedic solutions to better serve pediatric patients, with a focus on developing groundbreaking products [3]. Company Background - Founded in 2006, OrthoPediatrics specializes in pediatric orthopedics and offers over 80 products across major categories including trauma, deformity, scoliosis, and sports medicine [4]. - The company's global sales organization operates exclusively in pediatric orthopedics, distributing products in the U.S. and over 70 other countries [4].